Invention Grant
- Patent Title: Multispecific antibodies
-
Application No.: US15779424Application Date: 2016-12-01
-
Publication No.: US10774157B2Publication Date: 2020-09-15
- Inventor: Michael John Wright
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SRL
- Current Assignee: UCB BIOPHARMA SRL
- Current Assignee Address: BE Brussels
- Agency: Medler Ferro Woodhouse & Mills PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4ffe7183
- International Application: PCT/EP2016/079435 WO 20161201
- International Announcement: WO2017/093406 WO 20170608
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/00 ; C07K16/46 ; C07K16/14 ; C07K14/39

Abstract:
The present invention relates to heterodimerically-tethered bispecific protein complexes (according to the general formula of A(A1)n-X:Y-B(B1)m and libraries/multiplexes thereof for use in research and therapy and in particular an in vitro/ex vivo method of detecting synergistic biological function of otherwise unknown pairs of targets. Such complexes may be used to capture soluble molecules secreted from a particular cell, in therapy, in research and for experimental purposes such as in assays to characterise patient populations by identifying cell populations relevant to a pathology or prognosis.
Public/Granted literature
- US20180334514A1 MULTISPECIFIC ANTIBODIES Public/Granted day:2018-11-22
Information query